FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296340968> ?p ?o ?g. }

• W4296340968 endingPage "S563" @default.
• W4296340968 startingPage "S563" @default.
• W4296340968 abstract "Introduction: Bisphosphonates increase Bone mineral density (BMD) by suppressing bone turnover inhibiting osteoclastic function with risk of inducing adynamic bone disease. Teriparatide is a fragment of the natural human parathyroid hormone (PTH) consisting of the first 34 amino acids counting from the N-terminus end of the natural PTH. Is anabolic drugs stimulate bone formation by increasing osteoblast activity and regulates both bone formation and resorption reducing the risk of vertebral and nonvertebral fractures. Arm: Teriparatide (Parathormone 1-34) treatment in renal trasplant patients with bisphosphonate-resistent osteoporosis.Metods: observational describe study of cases series of 10 kidney transplant patients with bone fragility without response to prolonged treatment with bisphosphonates (greater than 3 years). They were treated with daily subcutaneous injections of 20 microg teriparatide (PTH 1-34) by 18 months. All the patients had 6 months of bisphosphonate wash out. Measurements: we investigated bone turnover markers and effect of teriparatide over BMD of the femoral neck and lumbar spine as well also fractures, graft rejection, cardiovascular events, death and drug related adverse event. Results: 10 patients 9 women, mean age 64.4±14.15 years, BMI 24.3 ±2.64, etiology 3GMN, 3 PKD, 3 unknown, 1 NDBT, HD 9, preempive 1, transplant Time 10.12±5.21 years, 1 preemptive, 8 DBD and 1 LRD, Induction: 8 thymoglobulin, 2 basiliximab, Maintenance 5 belatacept/mycophenolate/MTP, 2 rapamune/mycophenolate/MTP, 3 tacrolimus/mycophenolate/MTP, 6 patients with fractures prior to treatment. Mean of treatment with bisphosphonates 4.1±1.79 years. It is observed at 18 months of treatment with 1-34 PTH increased levels of bone alkaline phosphatase (13.26 UI/L ± 5.75 vs 17.90 ± 7.28, p = 0.045), with NS changes in the rest of the analytes (Table 1) and increase of lumbar bone density of 11.27% (0.8816 gr/cm2 (TS-2.6) vs 0.9941 gr/cm2 (TS-1.38)) and femoral neck of 7.07% (0.6752 gr/cm2(TS-2.5) vs 0.7230 gr/cm2(TS-2.19)). 2 patients presented wrist fractures during treatment with low response(lumbar BMD) to treatment. No cardiovascular events, rejections, deaths were reported. Adverse Events: 1 patient presented hypotension during the first month of treatment. Conclusion: In this group of patients, and adequate response to teriparatide treatment was observed however our limitation were small number of patients and bone biopsy prior teriparatide treatment." @default.
• W4296340968 created "2022-09-20" @default.
• W4296340968 creator A5020071397 @default.
• W4296340968 creator A5024330280 @default.
• W4296340968 creator A5040578616 @default.
• W4296340968 creator A5070882229 @default.
• W4296340968 creator A5082998535 @default.
• W4296340968 creator A5090380731 @default.
• W4296340968 creator A5090907525 @default.
• W4296340968 date "2022-09-01" @default.
• W4296340968 modified "2023-10-17" @default.
• W4296340968 title "P8.033: Teriparatide in Kidney Transplant Patients With Bisphosphonate-Resistent Osteoporosis" @default.
• W4296340968 doi "https://doi.org/10.1097/01.tp.0000888536.39488.70" @default.
• W4296340968 hasPublicationYear "2022" @default.
• W4296340968 type Work @default.
• W4296340968 citedByCount "0" @default.
• W4296340968 crossrefType "journal-article" @default.
• W4296340968 hasAuthorship W4296340968A5020071397 @default.
• W4296340968 hasAuthorship W4296340968A5024330280 @default.
• W4296340968 hasAuthorship W4296340968A5040578616 @default.
• W4296340968 hasAuthorship W4296340968A5070882229 @default.
• W4296340968 hasAuthorship W4296340968A5082998535 @default.
• W4296340968 hasAuthorship W4296340968A5090380731 @default.
• W4296340968 hasAuthorship W4296340968A5090907525 @default.
• W4296340968 hasBestOaLocation W42963409681 @default.
• W4296340968 hasConcept C126322002 @default.
• W4296340968 hasConcept C126894567 @default.
• W4296340968 hasConcept C134018914 @default.
• W4296340968 hasConcept C141071460 @default.
• W4296340968 hasConcept C170033053 @default.
• W4296340968 hasConcept C2776541429 @default.
• W4296340968 hasConcept C2776886416 @default.
• W4296340968 hasConcept C2777251235 @default.
• W4296340968 hasConcept C2777308945 @default.
• W4296340968 hasConcept C2779126354 @default.
• W4296340968 hasConcept C673006 @default.
• W4296340968 hasConcept C71924100 @default.
• W4296340968 hasConceptScore W4296340968C126322002 @default.
• W4296340968 hasConceptScore W4296340968C126894567 @default.
• W4296340968 hasConceptScore W4296340968C134018914 @default.
• W4296340968 hasConceptScore W4296340968C141071460 @default.
• W4296340968 hasConceptScore W4296340968C170033053 @default.
• W4296340968 hasConceptScore W4296340968C2776541429 @default.
• W4296340968 hasConceptScore W4296340968C2776886416 @default.
• W4296340968 hasConceptScore W4296340968C2777251235 @default.
• W4296340968 hasConceptScore W4296340968C2777308945 @default.
• W4296340968 hasConceptScore W4296340968C2779126354 @default.
• W4296340968 hasConceptScore W4296340968C673006 @default.
• W4296340968 hasConceptScore W4296340968C71924100 @default.
• W4296340968 hasIssue "9S" @default.
• W4296340968 hasLocation W42963409681 @default.
• W4296340968 hasLocation W42963409682 @default.
• W4296340968 hasOpenAccess W4296340968 @default.
• W4296340968 hasPrimaryLocation W42963409681 @default.
• W4296340968 hasRelatedWork W1967422973 @default.
• W4296340968 hasRelatedWork W2036148628 @default.
• W4296340968 hasRelatedWork W2041938128 @default.
• W4296340968 hasRelatedWork W2053638911 @default.
• W4296340968 hasRelatedWork W2096275148 @default.
• W4296340968 hasRelatedWork W2105853087 @default.
• W4296340968 hasRelatedWork W2128714854 @default.
• W4296340968 hasRelatedWork W2964737734 @default.
• W4296340968 hasRelatedWork W3118667905 @default.
• W4296340968 hasRelatedWork W4384664112 @default.
• W4296340968 hasVolume "106" @default.
• W4296340968 isParatext "false" @default.
• W4296340968 isRetracted "false" @default.
• W4296340968 workType "article" @default.